COUGHLIN TIMOTHY sold 15.1% of their position (10K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $500.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/16/2026ACC: 0001376043-26-000010
Director
Since May 2019
-10K
Net shares
Net seller
$500.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$26.52
Trade value
$265.20K
% of position
17.8%
6/12/2026
56.25K→66.25K
Common Stock
Direct
Shares
−10K
Price / share
$50.07
Trade value
$500.75K
% of position
15.1%
6/12/2026
66.25K→56.25K
Total
Net shares
+0.00
Net value
-$235.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2026 | M · Option Exercise | +10K | $26.52 | $265.20K | 17.8% | 56.25K | 66.25K |
| Common Stock Direct | 6/12/2026 | S · Sale | −10K | $50.07 | $500.75K | 15.1% | 66.25K | 56.25K |
| Total | +0.00 | -$235.55K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
26.52
Held after
0.00
Exercisable
—
6/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock10K shares | 6/12/2026 | M · Option Exercise | −10K | 26.52 | — | 0.00 |